Cytex Therapeutics

• Bradley T Estes

  Vp, research and development

• Vincent P Willard

  Director of research

• Farshid Guilak

Sources: reporter.nih.gov

• National Institute of Arthritis and Musculoskeletal and Skin Diseases

  SB1, Unicondylar Resurfacing in an Ovine Osteoarthritis Disease Model, SB1AR066439, $400K, 2015–2026, Jul 31, 2024

• National Institute on Aging

  SB1, Functional Tissue Engineering for Cartilage Repair, SB1AG059313, $383K, 2009–2021, May 6, 2019

• National Institute of Arthritis and Musculoskeletal and Skin Diseases

  R43, Evaluating the Safety and Efficacy of Cartilage Regeneration with Tunable Inflammation Resistance, R43AR073716, $225K, 2018–2021, Sep 18, 2018

• National Institute of Arthritis and Musculoskeletal and Skin Diseases

  R42, Unicondylar Resurfacing in an Ovine Osteoarthritis Disease Model, R42AR066439, $608K, 2017–2020, Apr 17, 2018

Sources: reporter.nih.gov

• Age-dependent effects of TRPA1 deficiency on pain and osteoarthritis pathology following joint injury in mice

  Employment, Shares or equity, Jul 22, 2026

• Gene therapy for fat-1 prevents obesity-induced metabolic dysfunction, cellular senescence, and osteoarthritis

  Employment, Shares or equity, Oct 14, 2024

Sources: pubmed.ncbi.nlm.nih.gov